A selected pre-amplification strategy for genetic analysis using limited DNA targets

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 3, 2009, Pages 288-293

  Xia, Peng ^a,b   Radpour, Ramin ^a   Kohler, Corina ^a   Dang, Cheng Xue ^b   Cheng Fan, Alex Xiu ^a   Holzgreve, Wolfgang ^c   Zhong, Xiao Yan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Genetic analysis; Limited DNA resources; Limited DNA target; Pre amplification; Quantitative real time PCR

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; TESTIS DETERMINING FACTOR;

ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; FEMALE; FETUS; GENE AMPLIFICATION; GENE LOCUS; GENE TARGETING; GENETIC ANALYSIS; HUMAN; MALE; MATERNAL PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; Y CHROMOSOME;

CELL-FREE SYSTEM; CHROMOSOMES, HUMAN, Y; DNA; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MALE; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 63849320791     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.067     Document Type: Article

References (23)

1. Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax? Best Pract Res Clin Obstet Gynaecol 2007;21:157-68.
2. Rico A, Ortiz-Barredo A, Ritter E, Murillo J. Genetic characterization of Erwinia amylovora strains by amplified fragment length polymorphism. J Appl Microbiol 2004; 96:302-10.
3. Bianchi DW, Wataganara T, Lapaire O, Tjoa ML, Maron JL, Larrabee PB, et al. Fetal nucleic acids in maternal body fluids: an update. Ann NY Acad Sci 2006;1075: 63-73.
4. Kuliev A, Verlinsky Y. Preimplantation genetic diagnosis: technological advances to improve accuracy and range of applications. Reprod Biomed Online 2008;16:532-8.
5. Bredenoord AL, Pennings G, Smeets HJ, de Wert G. Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update 2008;14:83-94.
6. Ferri G, Bini C, Ceccardi S, Ingravallo F, Lugaresi F, Pelotti S. Minisequencing-based genotyping of Duffy and ABO blood groups for forensic purposes. J Forensic Sci 2006;51:357-60.
7. Noutsias M, Rohde M, Block A, Klippert K, Lettau O, Blunert K, et al. Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol 2008;9:3.
8. Norbury G, Norbury CJ. Non-invasive prenatal diagnosis of single gene disorders: how close are we? Semin Fetal Neonatal Med 2008;13:76-83.
9. Zanetti-Dallenbach R, Wight E, Fan AX, Lapaire O, Hahn S, Holzgreve W, et al. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res 2008;28:921-5.
10. Zhong XY, Holzgreve W, Hahn S. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly 2001;131:70-4.
11. Troeger C, Zhong XY, Burgemeister R, Minderer S, Tercanli S, Holzgreve W, et al. Approximately half of the erythroblasts in maternal blood are of fetal origin. Mol Hum Reprod 1999;5:1162-5.
12. Zhong XY, Holzgreve W, Hahn S. Direct quantification of fetal cells in maternal blood by real-time PCR. Prenat Diagn 2006;26:850-4.
13. Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDITOF mass spectrometry. Prenat Diagn 2008;28:203-8.
14. Zhong XY, Kaul S, Eichler A, Bastert G. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow. Arch Gynecol Obstet 1999;263:2-6.
15. Zhong XY, Kaul S, Thompson J, Eichler A, Bastert G. Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood. J Cancer Res Clin Oncol 1999;125: 669-74.
16. Diel IJ, Solomayer EF, Bastert G. Micrometastatic cells in the bone marrow of patients with breast carcinoma. Radiologe 2000;40:681-7.
17. Bredel M, Bredel C, Juric D, Kim Y, Vogel H, Harsh GR, et al. Amplification of whole tumor genomes and geneby-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. J Mol Diagn 2005;7:171-82.
18. Schowalter KV, Fredrickson J, Thornhill AR. Efficient isothermal amplification of the entire genome from single cells. Methods Mol Med 2007;132:87-99.
19. Ballantyne KN, van Oorschot RA, Mitchell RJ. Compari son of two whole genome amplification methods for STR genotyping of LCN and degraded DNA samples. Forensic Sci Int 2007;166:35-41.
20. Zhong XY, Hahn S, Steinborn A, Holzgreve W. Quantitative analysis of intact fetal cells in maternal plasma by real-time PCR. Eur J Obstet Gynecol Reprod Biol 2007;133:20-4.
21. Zhong XY, Holzgreve W, Hahn S. Detection of fetal rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. Br J Obstet Gynaecol 2000;107:766-9.
22. Zhong XY, Hahn S, Holzgreve W. Prenatal identification of fetal genetic traits. Lancet 2001;357:310-1.
23. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. J Am Med Assoc 2005;293:843-9.